Welcure Drugs & Pharmaceuticals share news, announcements and annual reports
BSE: 524661Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹0.18.
30 Oct: open ₹0.18, high ₹0.19, low ₹0.17
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹22 Cr3,646th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 86,46,796
Welcure Drugs & Pharmaceuticals share news and announcements
550 announcements, routine notices left out, newest first. Page 3 of 11.
Jan 2025
Dec 2024
3 Dec · Meeting
2 Dec · Board meeting
Meeting on 2 Dec 2024
Nov 2024
14 Nov · Submission Of Half Yearly Disclosures On Related Party Transactions For A Period From 1St April, 2024 To 30Th September, 2024
7 Nov · Board meeting
Meeting on 14 Nov 2024: quarterly results
Oct 2024
21 Oct · Notice Of Forfeiture Of Partly Paid Up Shares Of The Company
21 Oct · Board meeting
17 Oct · Board meeting
Meeting on 21 Oct 20248 Oct · Statement Of Investor Grievances Under Regulation 13 (3) Of SEBI (LODR) Regulations, 2015
4 Oct · Board meeting
Meeting on 4 Oct 2024
Sep 2024
30 Sep · Meeting
30 Sep · Announcement under Regulation 30 (LODR)-Meeting Updates
28 Sep · Meeting
Aug 2024
29 Aug · Board meeting
Meeting on 2 Sep 2024: annual general meeting14 Aug · Results
8 Aug · Board meeting
Meeting on 8 Aug 20246 Aug · Board meeting
Meeting on 14 Aug 2024: quarterly results
Jul 2024
18 Jul · Board meeting
Meeting on 18 Jul 202417 Jul · Submission Of Disclosure Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
12 Jul · Announcement under Regulation 30 (LODR)-Demise
2 Jul · Revised Audited Standalone Financial Statements Of The Company For The Year Ended March 31,2024.
Jun 2024